Sharon Worcester is an award-winning medical journalist for MDedge News. She has been with the company since 1996, first as the Southeast Bureau Chief (1996-2009) when the company was known as International Medical News Group, then as a freelance writer (2010-2015) before returning as a reporter in 2015. She previously worked as a daily newspaper reporter covering health and local government. Sharon currently reports primarily on oncology and hematology. She has a BA from Eckerd College and an MA in Mass Communication/Print Journalism from the University of Florida. Connect with her via LinkedIn and follow her on twitter @SW_MedReporter.
Video
VIDEO: Cannabidiol reduces convulsive seizures in Dravet syndrome
BOSTON – Adjunctive treatment with cannabidiol significantly reduced convulsive seizure frequency in Dravet syndrome patients.
News
In mantle cell lymphoma, triple therapy proves too toxic
Combined idelalisib, lenalidomide, and rituximab proved excessively toxic for the treatment of relapsed and refractory mantle cell and follicular...
News
New guideline: Address GTCS frequency to reduce SUDEP risk
BOSTON – Generalized tonic-clonic seizures are a major risk factor for sudden unexpected death in epilepsy (SUDEP).
News
Prenotification, unequivocal stroke promote ultra-fast door-to-needle time
BOSTON – Prenotification by emergency medical services and unequivocal clinical scenarios help to achieve ultra-fast door-to-needle times of 10...
News
Optimum antithymocyte globulin exposure after HTC affects survival
Optimum antithymocyte globulin exposure after allogeneic hemopoietic cell transplantation plays an important role in survival.
News
Extended maraviroc helps prevent graft-versus-host disease
ORLANDO – Use of maraviroc for 90 days is safe and effective for prevention of graft-versus-host disease in allogeneic stem cell transplantation...
News
CDC: Some Shigella strains show reduced ciprofloxacin susceptibility
The CDC has identified an increase in Shigella isolates with reduced susceptibility to ciprofloxacin, and has released an official health...
News
Pegylated interferon alfa-2a induces durable responses in MPNs
Pegylated interferon alfa-2a can induce durable hematologic and molecular responses in patients with advanced essential thrombocythemia and...
News
Biomarker algorithm sharpens GVHD treatment outcomes prediction
ORLANDO – A biomarker algorithm was better than was clinical response at predicting outcomes after 1 week of systemic steroid treatment for graft-...
News
Preparing for pancreatic cancer ‘tsunami’ ahead
Overall cancer death rates are dropping dramatically, but pancreatic cancer mortality remains high.
News
FDA approves Sovaldi, Harvoni for HCV in ages 12-plus
The Food and Drug Administration has approved the use of Sovaldi (sofosbuvir) and Harvoni (ledipasvir and sofosbuvir) for the treatment of...
News
Myelofibrosis therapies moving beyond ruxolitinib
ORLANDO – A number of agents in clinical trials show promise for treatment of myelofibrosis.
News
NCCN myelofibrosis guideline: Patient voice is key
ORLANDO – Treatment decisions in myelofibrosis patients are complex and require patient input. A new treatment guideline from the NCCN addresses...
News
Safety of N9-GP for hemophilia B needs further study, FDA committee agrees
The investigational factor IX product nonacog beta pegol for the treatment of hemophilia B has a possible safety issue that had the Food and Drug...
News
Tocilizumab shows promise for GVHD prevention
ORLANDO – The interleuken-6 receptor blocker tocilizumab showed promising activity for preventing graft-versus-host disease when added to standard...